PRESS RELEASE published on 04/03/2026 at 17:45, 5 months 7 days ago Information relative aux actions et droits de vote EuroLand Corporate, société cotée sur Euronext Growth Paris, communique ses données financières au 31 mars 2026 Euronext Growth Paris Données Financières EuroLand Corporate Société Cotée 31 Mars 2026
BRIEF published on 03/09/2026 at 15:05, 6 months 1 day ago EuroLand Corporate launches the 4th edition of Retail Day EuroLand Corporate Vidéo Conférence Retail Day 2026 Small & Mid Caps Marc Fiorentino
BRIEF published on 03/09/2026 at 15:05, 6 months 1 day ago EuroLand Corporate lance la 4ème édition du Retail Day Visioconférence EuroLand Corporate Retail Day 2026 Small & Mid Caps Marc Fiorentino
PRESS RELEASE published on 03/09/2026 at 15:00, 6 months 1 day ago EuroLand Corporate annonce la quatrième édition de Retail Day le 7 avril 2026 EuroLand Corporate annonce la 4ème édition du Retail Day le 7 avril 2026, une visioconférence mettant en avant des pépites Small & Mid Caps avec des interviews d'entreprises et dirigeants Visioconférence EuroLand Corporate Entreprises Retail Day Small & Mid Caps
BRIEF published on 02/27/2026 at 18:05, 6 months 11 days ago Euroland Corporate: Information on shares and voting rights Voting Rights Actions Paris Euronext Growth EuroLand Corporate
BRIEF published on 02/27/2026 at 18:05, 6 months 11 days ago Euroland Corporate : Information sur les actions et droits de vote Droits De Vote Actions Paris Euronext Growth EuroLand Corporate
PRESS RELEASE published on 02/27/2026 at 18:00, 6 months 11 days ago Information relative aux actions et droits de vote Communiqué de presse sur les données d'actionnariat d'Euroland Corporate incluant le nombre d'actions en circulation et les droits de vote associés Euronext Growth Paris Droits De Vote Actionnariat Communiqué De Presse EuroLand Corporate
BRIEF published on 02/20/2026 at 18:05, 6 months 18 days ago Euroland Corporate: Progres Share Buybacks Euronext Growth Redemption MAR Regulations EuroLand Corporate Clean Actions
BRIEF published on 02/20/2026 at 18:05, 6 months 18 days ago Euroland Corporate: Rachats d'Actions Progres Actions Propres Euronext Growth Rachat EuroLand Corporate Réglementation MAR
PRESS RELEASE published on 02/20/2026 at 18:00, 6 months 18 days ago Déclaration des transactions sur actions propres Euroland Corporate déclare les rachats d'actions propres conformément au règlement Abus de marché (MAR) sur les 7 derniers jours de bourse et détient 237.377 actions propres au 20 février 2026 Actions Propres Euronext Growth Abus De Marché EuroLand Corporate Rachats D'actions
Published on 09/11/2026 at 04:00, 5 hours 45 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 20 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 25 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 45 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 25 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 39 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 45 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 45 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 45 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 45 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 15 minutes ago Availability of the 2026 Interim Financial Report
